基于特征离子的血竭和龙血竭UPLC-QTOF/MS定性鉴别方法的建立
Identification of Draconis Sanguis and Resina Draconis based on characteristic ions by UPLC-QTOF/MS
分类号:
出版年·卷·期(页码):2015,35 (10):0-0
DOI:
10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------
目的: 寻找血竭和龙血竭药材的专属性成分,形成以特征离子为目标的鉴别方法。方法: 利用超高效液相色谱-四极杆飞行时间-质谱(UPLC-QTOF/MS)进行测定,采用Markerlynx软件对血竭和龙血竭药材的质谱数据进行主成分分析,找出对区分药材有贡献的色谱峰,并采用软件对差异性成分进行鉴定。LC-MS条件:采用ACQUITY UPLC BEH C18(2.1 mm×100 mm,1.7 μm)色谱柱,以0.1%甲酸水溶液(A)-乙腈(B)为流动相,梯度洗脱(0~10 min,5%B→95%B;10~11 min,95%B;11~11.1 min,95%B→5%B;11.1~15 min,5%B),流速0.25 mL·min-1,柱温40 ℃;质谱采用离子化模式为ESI+,毛细管电压3.0 kV,锥孔电压35 V,离子源温度105 ℃,扫描范围m/z 50~1 500。结果: 根据主成分分析,血竭和龙血竭分别聚在不同的区域,显示血竭和龙血竭的化学成分有差异,可作为血竭和龙血竭的定性鉴别方法。结论: 建立的方法可以用于区分血竭和龙血竭的定性鉴别。
-----英文摘要:---------------------------------------------------------------------------------------
Objective: To search specific components and establish method for the identification of Draconis Sanguts and Resina Draconis based on characteristic ions.Methods: The sample was analyzed on a UPLC coupled with QTOF mass spectrometry.The UPLC-MS data of samples were subjected to principal component analysis(PCA)in order to find the marker constituents.LC-MS conditions were as follows.The chromatographic column was ACQUITY UPLC BEH C18 column(2.1 mm×100 mm, 1.7 μm), the mobile phase was composed of 0.1% formic acid(A)and acetonitrile(B)with gradient elution(0-10 min, 5%B→95%B;10-11 min, 95%B;11-11.1 min, 95%B→5%B;11.1-15 min, 5%B), the flow rate was 0.25 mL·min-1, and the column temperature was 40 ℃;the ionization mode was ESI+, the capillary voltage was 3.0 kV, the cone voltage was 35 V, and the ion source temperature was set at 105 ℃ at a scanning range of m/z 50-1 500.Results: According to the results of PCA, Draconis Sanguts and Resina Draconis clustered in different regions and characteristic ions were found by OPLS.method for the identification of Draconis Sanguts and Resina Draconis based on characteristic ions was established.Conclusion: This method can be used for the identification of Draconis Sanguts and Resina Draconis.
-----参考文献:---------------------------------------------------------------------------------------
[1] ChP 2010.Vol Ⅰ(中国药典2010年版.一部)[S].2010:133
[2] The National Drug Standard, New Drug Obtainment of Traditional Chinese Medicine.Vol 22(国家药品标准·新药转正标准中药.第22册)[S].1999:651
[3] HU YQ(胡迎庆), GONG B(宫飚), TU PF(屠鹏飞).Study on chemical constituents and their biological activities(龙血树属植物化学成分及活性的研究)[J].World Phytomed(国外医药·植物药分册), 2000, 15(1):5
[4] A LD(阿拉丁), GUO YP(郭亚苹), LI L(李丽), et al.Comparing Chinese and foreign Resina Draconis research(进口血竭与国产血竭的比较性研究)[J].Guangdong Chem Ind(广东化工), 2015, 42(294):18
[5] ZHANG L(张琳), LV HC(吕华冲), WANG JZ(王建壮).Qualitative analysis and comparisionof tatol flavones between Chinese and import Dragon's blood(进口血竭和国产血竭中总黄酮的鉴别比较研究)[J].J Guangdong Pharm Univ(广东药学院学报), 2012, 28(3):263
[6] SONG XY(宋雪英).Study to compare fingerprinting of foreign Resina Draconis crude drugs with that of native ones(进口血竭药材与国产血竭指纹图谱的比较研究)[J].Chin J Mod Appl Pharm(中国现代应用药学), 2007, 24(4):291
[7] SONG QL(宋前流), HU SF(胡双丰).Identification of Draconis Sanguts and Resina Draconis by TIC and UV(薄层色谱与紫外光谱联合鉴别血竭与龙血竭)[J].China Pharm(中国药师), 2009, 12(9):1314
[8] CHENG XL, WEI F, CHEN J, et al.Using the doubly charged selected ion coupled with MS/MS fragments monitoring(DCSI-MS/MS)mode for the identification of gelatin species[J].J Anal Methods Chem, 2014:764397.doi:10.1155/2014/764397.Epub 2014 Mar 13
[9] CHENG XL, XU LY, WEI F, et al.Identification of raw Cuscutae Semen and its processed products by high performance liquid chromatography/diode-array detection/mass spectrometry(HPLC-DAD-MS)combined with principle component analysis[J].J Liq Chromatogr Relat Technol, 2014, 37(5):748
[10] CHENG XL(程显隆), ZHANG XL(张小龙), LI WJ(李文杰), et al.Identification of bovine-hide gelatin from glue of tortoise shell and deer-horn gelatin by UPLC-QTOF-MS and principal component analysis(UPLC-QTOF-MS结合主成分分析法用于龟甲胶、鹿角胶中添加牛皮成分的检测研究)[J].Chin J Pharm Anal(药物分析杂志), 2012, 32(6):931
欢迎阅读《药物分析杂志》!您是该文第 935位读者!